Cerenion Revenue and Competitors

License our Company Data API

Oulu,

Location

N/A

Total Funding

Analytics

Industry

Estimated Revenue & Valuation

Cerenion's estimated annual revenue is currently $2.1M per year.(i)
Cerenion's estimated revenue per employee is $98,000

Employee Data

Cerenion has 21 Employees.(i)
Cerenion grew their employee count by -9% last year.

Cerenion's People

Name	Title	Email/Phone
1 Jukka Kortelainen	CEO	Reveal Email/Phone
2 Timo Koskela	Co-Founder, Chief Financial Officer	Reveal Email/Phone
3 Kaisu Sutinen	Sales and Marketing Director	Reveal Email/Phone
4 Tarja Suhonen	Customer Success Manager	Reveal Email/Phone
5 Terhimaria Kaski	Software Engineer	Reveal Email/Phone
6 Salla Hiltunen	Master's Thesis Worker	Reveal Email/Phone
7 Tamás Tóth	IT System Specialist	Reveal Email/Phone

Cerenion Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Mersive	$13.3M	95	-35%	$14.1M	N/A
#2 Quantum Metric	$87.3M	491	-3%	$251M	N/A
#3 Intellectyx	$15.5M	111	11%	N/A	N/A
#4 GitPrime	$14.6M	0	N/A	$12.5M	N/A
#5 Aunalytics	$32.8M	213	-6%	N/A	N/A
#6 250ok	$0.4M	12	100%	$2.6M	N/A
#7 Blue Ridge	$55.3M	316	2%	N/A	N/A
#8 AnswerRocket	$4.7M	42	-2%	N/A	N/A
#9 AHEAD	$431.2M	2200	40%	N/A	N/A
#10 Arity	$45.9M	298	4%	N/A	N/A

Add Company

Show More Analytics Companies

What Is Cerenion?

We provide the AI tools for the analysis of brain function in intensive care. CERENION C-TRENDâ„¢ offers the first truly objective and practical method to obtain reliable information on the condition and function of the brain. The clinically validated measure can be integrated into EEG-measurement devices and patient monitors as a software feature. CERENION C-TRENDâ„¢ is a medical-grade software solution that works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The result is a simple index that measures the condition and function of the brain on a scale from 0 to 100. The technology has the potential of improving both the quality and the cost of intensive care. Note: This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Under no circumstances shall the information on this website be construed as an advertisement of any commercially available product. Cerenionâ„¢, Cerenion C-Trendâ„¢, C-Trendâ„¢ and "The pulse of the brain"â„¢ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. Patents pending worldwide. All rights reserved. Â© Cerenion Oy 2017.

keywords:N/A

N/A

Total Funding

Number of Employees

$2.1M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator